What's on biopharma's auction block? EY tracks a growing appetite for pipeline divestment deals
Last fall the research arm of the Financial Times went out and took the industry’s pulse on dealmaking. And they found that there’s been a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
